Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/SUO Guideline (2017; Amended 2020, 2024)
The University of Kansas Cancer Center · American Urological Association · +5 more institutions
Indexed incrossrefpubmed
Abstract
Results
Updates were made regarding neoadjuvant/adjuvant chemotherapy, radical cystectomy, pelvic lymphadenectomy, multi-modal bladder preserving therapy, and future directions. Further revisions were made to the methodology and reference sections as appropriate.
Conclusions
This guideline seeks to improve clinicians' ability to evaluate and treat patients with MIBC based on currently available evidence. Future studies will be essential to further support or refine these statements to improve patient care.
Citation impact
164
total citations
- FWCI
- 82.98
- Percentile
- 100%
- References
- 51
Citations per year
Authors
9Topics & keywords
Topics
Keywords
- Medicine
- Guideline
- Bladder cancer
- Urology
- Oncology
- Internal medicine
- Gynecology
- Cancer
No related works found for this paper.